By KAI ICHINO/ Staff Writer
December 23, 2021 at 18:59 JST
A health ministry official on Dec. 22 announces a decision by the ministry’s expert panel to continue discussing whether to approve the use of aducanumab as a treatment for Alzheimer's-type dementia. (Kai Ichino)
A health ministry expert panel deferred approving the use of aducanumab as a treatment for Alzheimer's-type dementia, citing a need for more data on the drug’s efficacy through a clinical trial that will take years. [Read More]
A peek through the music industry’s curtain at the producers who harnessed social media to help their idols go global.
A series based on diplomatic documents declassified by Japan’s Foreign Ministry
Here is a collection of first-hand accounts by “hibakusha” atomic bomb survivors.
Cooking experts, chefs and others involved in the field of food introduce their special recipes intertwined with their paths in life.
A series about Japanese-Americans and their memories of World War II
